The role of area-level deprivation and gender in participation in population-based faecal immunochemical test (FIT) colorectal cancer screening

Preventive Medicine

Volumn 93, Issue , 2016, Pages 198-203

  Clarke, Nicholas ^a   McNamara, Deirdre ^b   Kearney, Patricia M ^a   O'Morain, Colm A ^b   Shearer, Nikki ^b   Sharp, Linda ^c  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Cancer; Colorectal; Deprivation; Faecal Immunochemical Test; FIT; Gender; Participation; Screening

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOCHEMISTRY; IRELAND; MAJOR CLINICAL STUDY; MALE; PATIENT PARTICIPATION; PRIORITY JOURNAL; SEX DIFFERENCE; COLORECTAL TUMOR; EARLY CANCER DIAGNOSIS; IMMUNOHISTOCHEMISTRY; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; POVERTY; PROCEDURES; STATISTICS AND NUMERICAL DATA;

COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IRELAND; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT PARTICIPATION; POVERTY; SEX FACTORS;

EID: 84992504057     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2016.10.012     Document Type: Article

References (38)

1. Atkin, W.S., Edwards, R., Kralj-Hans, I., Wooldrage, K., Hart, A.R., Northover, J.M.A., Parkin, D.M., Wardle, J., Duffy, S.W., Cuzick, J., UK Flexible Sigmoidoscopy Trial Investigators, Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375 (2010), 1624–1633, 10.1016/S0140-6736(10)60551-X.
2. Bonita, R., Beaglehole, R., Kjellström, T., Basic Epidemiology. 2th ed, 2006, World Health Organization, Geneva.
3. Brenner, H., Kloor, M., Pox, C.P., Colorectal cancer. Lancet 383 (2014), 1490–1502, 10.1016/S0140-6736(13)61649-9.
4. Brenner, H., Stock, C., Hoffmeister, M., Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ, 348, 2014, g2467.
5. Burch, J.A., Soares-Weiser, K., St John, D.J.B., Duffy, S., Smith, S., Kleijnen, J., Westwood, M., Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J. Med. Screen. 14 (2007), 132–137, 10.1258/096914107782066220.
6. Clarke, N., Sharp, L., Osborne, A., Kearney, P.M., Comparison of ptake of colorectal cancer screening based on fecal immunochemical testing (FIT) in males and females: a systematic review and meta-analysis. Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol. 24 (2015), 39–47, 10.1158/1055-9965.EPI-14-0774.
7. Clarke, N., Gallagher, P., Kearney, P.M., McNamara, D., Sharp, L., Impact of gender on decisions to participate in faecal immunochemical test-based colorectal cancer screening: a qualitative study: impact of gender on decision to participate in FIT screening. Psychooncology, 2016, 10.1002/pon.4085 (n/a–n/a).
8. CSO, Small area population statistics. http://www.cso.ie/px/pxeirestat/Statire/SelectVarVal/Define.asp?Maintable=CD115&Planguage=0;, 2011 (Date accessed 26/08/2016).
9. CSO, Men and Women in Ireland 2013. 2014.
10. Digby, J., McDonald, P.J., Strachan, J.A., Libby, G., Steele, R.J., Fraser, C.G., Use of a faecal immunochemical test narrows current gaps in uptake for sex, age and deprivation in a bowel cancer screening programme. J. Med. Screen. 20 (2013), 80–85, 10.1177/0969141313497197.
11. Doyle, G., Cafferkey, K., Fullam, J., The European Health Literacy Survey: Results from Ireland. 2012, Dublin Irel. Univ. Coll, Dublin.
12. Engling, F., Haase, T., The 2011 Pobal HP Deprivation Index: Area Profile for South County Dublin (No. 03). 2013, Trutz Haase: Social & Economic Consultant.
13. Essink-Bot, M.-L., Dekker, E., Equal access to colorectal cancer screening. Lancet, 2015, 10.1016/S0140-6736(15)01221-0.
14. European Colorectal Cancer Screening Guidelines Working Group, von Karsa, L., Patnick, J., Segnan, N., Atkin, W., Halloran, S., Lansdorp-Vogelaar, I., Malila, N., Minozzi, S., Moss, S., Quirke, P., Steele, R.J., Vieth, M., Aabakken, L., Altenhofen, L., Ancelle-Park, R., Antoljak, N., Anttila, A., Armaroli, P., Arrossi, S., Austoker, J., Banzi, R., Bellisario, C., Blom, J., Brenner, H., Bretthauer, M., Camargo Cancela, M., Costamagna, G., Cuzick, J., Dai, M., Daniel, J., Dekker, E., Delicata, N., Ducarroz, S., Erfkamp, H., Espinàs, J.A., Faivre, J., Faulds Wood, L., Flugelman, A., Frkovic-Grazio, S., Geller, B., Giordano, L., Grazzini, G., Green, J., Hamashima, C., Herrmann, C., Hewitson, P., Hoff, G., Holten, I., Jover, R., Kaminski, M.F., Kuipers, E.J., Kurtinaitis, J., Lambert, R., Launoy, G., Lee, W., Leicester, R., Leja, M., Lieberman, D., Lignini, T., Lucas, E., Lynge, E., Mádai, S., Marinho, J., Maučec Zakotnik, J., Minoli, G., Monk, C., Morais, A., Muwonge, R., Nadel, M., Neamtiu, L., Peris Tuser, M., Pignone, M., Pox, C., Primic-Zakelj, M., Psaila, J., Rabeneck, L., Ransohoff, D., Rasmussen, M., Regula, J., Ren, J., Rennert, G., Rey, J., Riddell, R.H., Risio, M., Rodrigues, V., Saito, H., Sauvaget, C., Scharpantgen, A., Schmiegel, W., Senore, C., Siddiqi, M., Sighoko, D., Smith, R., Smith, S., Suchanek, S., Suonio, E., Tong, W., Törnberg, S., Van Cutsem, E., Vignatelli, L., Villain, P., Voti, L., Watanabe, H., Watson, J., Winawer, S., Young, G., Zaksas, V., Zappa, M., Valori, R., European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy 45 (2013), 51–59, 10.1055/s-0032-1325997.
15. Gimeno García, A.Z., Factors influencing colorectal cancer screening participation. Gastroenterol. Res. Pract., 2012, 2011, e483417, 10.1155/2012/483417.
16. Globocan, GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012 [WWW document]. URL http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx?cancer=colorectal, 2012 (accessed 1.26.16).
17. Hewitson, P., Glasziou, P., Watson, E., Towler, B., Irwig, L., Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am. J. Gastroenterol. 103 (2008), 1541–1549, 10.1111/j.1572-0241.2008.01875.x.
18. Institute of Medicine (US) Committee on Health Literacy, Health Literacy: A Prescription to End Confusion. 2004, National Academies Press (US), Washington (DC).
19. Javanparast, S., Ward, P., Young, G., Wilson, C., Carter, S., Misan, G., Cole, S., Jiwa, M., Tsourtos, G., Martini, A., Gill, T., Baratiny, G., Matt, M.A., How equitable are colorectal cancer screening programs which include FOBTs? A review of qualitative and quantitative studies. Prev. Med. 50 (2010), 165–172, 10.1016/j.ypmed.2010.02.003.
20. Khalid-de Bakker, C., Jonkers, D., Smits, K., Mesters, I., Masclee, A., Stockbrügger, R., Participation in colorectal cancer screening trials after first-time invitation: a systematic review. Endoscopy 43 (2011), 1059–1086, 10.1055/s-0031-1291430.
21. Kobayashi, L.C., Wardle, J., von Wagner, C., Limited health literacy is a barrier to colorectal cancer screening in England: evidence from the English longitudinal study of ageing. Prev. Med. 61 (2014), 100–105, 10.1016/j.ypmed.2013.11.012.
22. Levin, B., Lieberman, D.A., McFarland, B., Andrews, K.S., Brooks, D., Bond, J., Dash, C., Giardiello, F.M., Glick, S., Johnson, D., Johnson, C.D., Levin, T.R., Pickhardt, P.J., Rex, D.K., Smith, R.A., Thorson, A., Winawer, S.J., American Cancer Society Colorectal Cancer Advisory Group, US Multi-Society Task Force, American College of Radiology Colon Cancer Committee, Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US multi-society task force on colorectal cancer, and the American College of Radiology. Gastroenterology 134 (2008), 1570–1595, 10.1053/j.gastro.2008.02.002.
23. Lyratzopoulos, G., Liu, M.P.-H., Abel, G.A., Wardle, J., Keating, N.L., The association between fatalistic beliefs and late stage at diagnosis of lung and colorectal cancer. Cancer Epidemiol. Biomark. Prev. 24 (2015), 720–726, 10.1158/1055-9965.EPI-14-0969.
24. Manser, C.N., Bauerfeind, P., Impact of socioeconomic status on incidence, mortality, and survival of colorectal cancer patients: a systematic review. Gastrointest. Endosc., 80, 2014, 42-60.e9, 10.1016/j.gie.2014.03.011.
25. McNamara, D., Leen, R., Seng-Lee, C., Shearer, N., Crotty, P., Neary, P., Walsh, P., Boran, G., O'Morain, C., Sustained participation, colonoscopy uptake and adenoma detection rates over two rounds of the Tallaght-trinity college colorectal cancer screening programme with the faecal immunological test. Eur. J. Gastroenterol. Hepatol. 26 (2014), 1415–1421, 10.1097/MEG.0000000000000207.
26. Miles, A., Rainbow, S., von Wagner, C., Cancer fatalism and poor self-rated health mediate the association between socioeconomic status and uptake of colorectal cancer screening in England. Cancer Epidemiol. Biomark. Prev. 20 (2011), 2132–2140, 10.1158/1055-9965.EPI-11-0453.
27. National Cancer Institute, Colorectal cancer screening (PDQ®) [WWW document]. J. Natl. Cancer Inst., 2012 URL http://www.cancer.gov/cancertopics/pdq/screening/colorectal/HealthProfessional/page1 (accessed 10.17.14).
28. Powe, B.D., Finnie, R., Cancer fatalism: the state of the science. Cancer Nurs. 26 (2003), 454–467.
29. Solmi, F., Von Wagner, C., Kobayashi, L.C., Raine, R., Wardle, J., Morris, S., Decomposing socio-economic inequality in colorectal cancer screening uptake in England. Soc. Sci. Med. 134 (2015), 76–86, 10.1016/j.socscimed.2015.04.010.
30. Sørensen, K., Pelikan, J.M., Röthlin, F., Ganahl, K., Slonska, Z., Doyle, G., Fullam, J., Kondilis, B., Agrafiotis, D., Uiters, E., Falcon, M., Mensing, M., Tchamov, K., van den Broucke, S., Brand, H., Health literacy in Europe: comparative results of the European health literacy survey (HLS-EU). Eur. J. Pub. Health 25 (2015), 1053–1058, 10.1093/eurpub/ckv043.
31. Vart, G., Banzi, R., Minozzi, S., Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis. Prev. Med. 55 (2012), 87–92, 10.1016/j.ypmed.2012.05.006.
32. von Wagner, C., Semmler, C., Good, A., Wardle, J., Health Literacy and Self-Efficacy for Participating in Colorectal Cancer Screening: The Role of Information Processing. Patient Educ. Couns, Vol. 75, 2009, Breidging the International Divide for Health Literacy Research, 352–357, 10.1016/j.pec.2009.03.015.
33. von Wagner, C., Baio, G., Raine, R., Snowball, J., Morris, S., Atkin, W., Obichere, A., Handley, G., Logan, R.F., Rainbow, S., Smith, S., Halloran, S., Wardle, J., Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int. J. Epidemiol. 40 (2011), 712–718, 10.1093/ije/dyr008.
34. Walsh, B., Silles, M., O'Neill, C., The role of private medical insurance in socio-economic inequalities in cancer screening uptake in Ireland: private insurance and medical screening in the Republic of Ireland. Health Econ. 21 (2012), 1250–1256, 10.1002/hec.1784.
35. Wardle, J., Robb, K., Vernon, S., Waller, J., Screening for prevention and early diagnosis of cancer. Am. Psychol. 70 (2015), 119–133, 10.1037/a0037357.
36. Wardle, J., von Wagner, C., Kralj-Hans, I., Halloran, S.P., Smith, S.G., McGregor, L.M., Vart, G., Howe, R., Snowball, J., Handley, G., Logan, R.F., Rainbow, S., Smith, S., Thomas, M.C., Counsell, N., Morris, S., Duffy, S.W., Hackshaw, A., Moss, S., Atkin, W., Raine, R., Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS bowel cancer screening programme (ASCEND): four cluster-randomised controlled trials. Lancet Lond. Engl., 2015, 10.1016/S0140-6736(15)01154-X.
37. Weller, D.P., Patnick, J., McIntosh, H.M., Dietrich, A.J., Uptake in cancer screening programmes. Lancet Oncol. 10 (2009), 693–699, 10.1016/S1470-2045(09)70145-7.
38. Zou, G., A modified Poisson regression approach to prospective studies with binary data. Am. J. Epidemiol. 159 (2004), 702–706, 10.1093/aje/kwh090.